Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study (Q35475549)
scientific article
Language:
(P31) (Q13442814)
(P304) 1071-1079
(P407) (Q1860)
(P433) 8
(P478) 74
(P577) Friday, August 1, 2003
(P921) (Q269829)
(Q11085)
(P1433) (Q1599804)
(P1476) "Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study" (language: en)
(P2093) D J Brooks
H Sagar
UK-Irish Entacapone Study Group
(P2860) (Q35572190)
(Q48712868)
(Q31402560)
(Q33944053)
(Q35456745)
(Q33786388)
(Q33648357)
(Q33537438)
(Q42540259)
(Q53590333)
(Q36317207)
(Q42547557)
(Q40981288)
(Q41351656)
(Q48125712)
(Q33731230)
(Q40579561)
(Q46654208)
(Q48438194)
(Q28317866)
(Q43709671)
(Q43692040)
(Q43658104)
(Q43539606)
(Q53986962)
(Q64877938)
(Q64854711)
(Q73957097)
(Q70669096)
(Q64867890)
(Q67234347)
(Q67220188)
(Q64955113)
other details
description scientific article

External Links